14-3-3 proteins are promising LRRK2 interactors

Biochemical Journal

Volumn 430, Issue 3, 2010, Pages

  Rudenko, Iakov N ^a   Cookson, Mark R ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

14 3 3 protein; Leucine rich repeat kinase 2 (LRRK2); Parkinson's disease; Phosphorylation; Protein protein interaction

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; PROTEIN 14 3 3; SERINE; GREEN FLUORESCENT PROTEIN; LRRK2 PROTEIN, MOUSE; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE;

AMINO TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; DIMERIZATION; NOTE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; 3T3 CELL LINE; ANIMAL; BINDING SITE; CELL LINE; CYTOPLASM; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; METABOLISM; MOUSE; MUTATION; PHOSPHORYLATION;

14-3-3 PROTEINS; ANIMALS; BINDING SITES; CELL LINE; CYTOPLASM; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; MICROSCOPY, FLUORESCENCE; MUTATION; PARKINSON DISEASE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; SERINE; SWISS 3T3 CELLS;

EID: 77956704554     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20101200     Document Type: Note

References (10)

1. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B. et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607
2. Paisan-Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simon, J., van der Brug, M., Lopez de Munain, A., Aparicio, S., Gil, A. M., Khan, N. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595-600
3. Greggio, E. and Cookson, M. R. (2009) Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.ASNNEURO1, art:e00002.doi:10.1042/AN20090007
4. Marin, I., van Egmond, W. N. and van Haastert, P. J. M. (2008) The Roco protein family: a functional perspective. FASEB J. 22, 3103-3110
5. Morrison, D. K. (2008) The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 19, 16-23
6. Nichols, R. J., Dzamko, N., Morrice, N. A., Campbell, D. G., Deak, M., Ordureau, A., Macartney, T., Tong, Y., Shen, J., Prescott, A. R. and Alessi, D. R. (2010) 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization. Biochem. J. 430, 393-404
7. Greggio, E., Zambrano, I., Kaganovich, A., Beilina, A., Taymans, J.-M., Daniels, V., Lewis, P., Jain, S., Ding, J., Syed, A. et al. (2008) The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J. Biol. Chem. 283, 16906-16914
8. Sen, S., Webber, P. J. and West, A. B. (2009) Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. J. Biol. Chem. 284, 36346-36356
9. Berger, Z., Smith, K. A. and Lavoie, M. J. (2010) Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation. Biochemistry 49, 5511-5523
10. Gloeckner, C. J., Boldt, K., von Zweydorf, F., Helm, S., Wiesent, L., Sarioglu, H. and Ueffing, M. (2010) Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2. J. Proteome Res. 9, 1738-1745